Voyager Therapeutics VYGR
NASDAQ VYGR
$1.76 -0.07 (-3.56%)
At close: Nov 11, 2026 · 4:00 PM EST

Voyager Therapeutics (VYGR) Net Income Attributable to Noncontrolling Interests (2015 - 2025)

Updated

Analysis

Voyager Therapeutics (VYGR) Net Income Attributable to Noncontrolling Interests (2015 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) NCI Net Income (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 2.00 Mn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 2.00 Mn
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -1.00 Mn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 10.00 Mn
10 Voyager Therapeutics 113.78 Mn -447.29 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -119.70 Mn
Sep 30, 2025 228,000.00
Dec 31, 2024 -65.38 Mn
Sep 30, 2024 489,000.00
Mar 31, 2023 124.13 Mn
Dec 31, 2022 -23.51 Mn
Sep 30, 2022 17.65 Mn
Mar 31, 2022 -21.40 Mn
Dec 31, 2021 -51.77 Mn
Sep 30, 2021 -25.14 Mn
Mar 31, 2021 11,000.00
Dec 31, 2020 -33.22 Mn
Sep 30, 2020 85.41 Mn
Mar 31, 2020 525,000.00
Dec 31, 2019 -12.66 Mn
Sep 30, 2019 -15.12 Mn
Jun 30, 2019 11.33 Mn
Mar 31, 2019 58,000.00
Jun 30, 2018 -25.50 Mn
Mar 31, 2018 125,000.00
API Access

Voyager Therapeutics Net Income Attributable to Noncontrolling Interests API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-non-controlling-interests&ticker=VYGR&period=max&api_key=YOUR_API_KEY